We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-14.56%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$688M
AUM Growth
-$52M
Cap. Flow
-$219M
Cap. Flow %
-31.89%
Top 10 Hldgs %
65.57%
Holding
231
New
46
Increased
68
Reduced
48
Closed
44

Top Buys

Rank Stock Value
1
AIOS
AIOS Tech
AIOS
+$28.5M
2
AGMH icon
AGM Group Holdings
AGMH
+$13.2M
3
OG
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
+$7.66M
4
ESPR
Esperion Therapeutics
ESPR
+$7.53M
5
CNTX icon
Context Therapeutics
CNTX
+$6.14M

Top Sells

Rank Stock Value
1
ZNB
Zeta Network Group
ZNB
+$3.39M
2
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$3.33M
3
TCDA
Tricida, Inc. Common Stock
TCDA
+$3.06M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$2.84M
5
FLUX icon
Flux Power
FLUX
+$2.59M

Sector Composition

Rank Sector Weight
1 Healthcare 7.43%
2 Technology 5.89%
3 Financials 5.84%
4 Consumer Discretionary 1.07%
5 Industrials 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATHX
176
PUT
DELISTED
Athersys, Inc. Common Stock
ATHX
$28K ﹤0.01%
12
– –
HEPA
177
PUT
DELISTED
Hepion Pharmaceuticals
HEPA
– –
0
– –
HEPA
178
DELISTED
Hepion Pharmaceuticals
HEPA
$23K ﹤0.01%
+20
New +$27.4K
AGTC
179
PUT
DELISTED
Applied Genetic Technologies Corporation
AGTC
$23K ﹤0.01%
+120
New +$287
DMK
180
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$19K ﹤0.01%
5
-26
-84% -$1.62K
FEED
181
ENvue Medical Inc
FEED
$1.95M
$10K ﹤0.01%
5
– –
GROMW
182
DELISTED
Grom Social Enterprises Inc. Warrants
GROMW
$7K ﹤0.01%
425
-557
-57% -$14.3K
ITP icon
183
PUT
IT Tech Packaging
ITP
$2.82M
$6K ﹤0.01%
25
– –
ITP icon
184
IT Tech Packaging
ITP
$2.82M
$3K ﹤0.01%
+1,157
New +$3.9K
ABVC icon
185
ABVC BioPharma
ABVC
$28.1M
– –
-7,156
Closed -$165K
ZNB
186
Zeta Network Group
ZNB
$656K
– –
0
– -$3.39M
ATER icon
187
PUT
Aterian
ATER
$4.23M
– –
-108
Closed -$1.4M
AUTL
188
CALL
Autolus Therapeutics
AUTL
$407M
– –
-409
Closed -$268K
BFLY icon
189
CALL
Butterfly Network
BFLY
$2.14B
– –
-3,503
Closed -$3.66M
GYRE icon
190
CALL
Gyre Therapeutics
GYRE
$648M
– –
-114
Closed -$350K
QTEX
191
QTREX Quantum
QTEX
$46.2M
– –
-102,553
Closed -$275K
QTEXW
192
DELISTED
QTREX Quantum Warrant
QTEXW
– –
-253,063
Closed -$208K
IONS icon
193
Ionis Pharmaceuticals
IONS
$8.81B
– –
-84,600
Closed -$2.84M
IONS icon
194
PUT
Ionis Pharmaceuticals
IONS
$8.81B
– –
-846
Closed -$2.84M
ORIO
195
Orion Digital Corp
ORIO
$15.2M
– –
-137,353
Closed -$1.98M
OCUL icon
196
CALL
Ocular Therapeutix
OCUL
$1.85B
– –
-5,115
Closed -$5.12M
OCUL icon
197
Ocular Therapeutix
OCUL
$1.85B
– –
-142,000
Closed -$1.42M
OCUL icon
198
PUT
Ocular Therapeutix
OCUL
$1.85B
– –
-2,097
Closed -$2.1M
ORMP icon
199
Oramed Pharmaceuticals
ORMP
$169M
– –
-40,344
Closed -$887K
ORMP icon
200
PUT
Oramed Pharmaceuticals
ORMP
$169M
– –
-972
Closed -$2.14M
6 7
8
9 10

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AB
Aozora Bank Tokyo, Japan $43.6M AUM 1.15% 1-Year Est. Return

Sabby Management's Q4 2021 Portfolio in Review

As of Q4 2021, Sabby Management held 231 positions worth $688M, down 7% from $740M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Sabby Management withdrew a net $219M in Q4 2021, closing 44 positions and reducing 48 holdings. Its most notable exit was Tricida, Inc. Common Stock, an estimated $3.06M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.4% of assets, up from 6.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Sabby Management opened a new position in AIOS Tech worth $10.4M.

  • Sabby Management's largest Q4 2021 buy was AIOS Tech: 16,134 shares worth $10.4M.
  • Sabby Management added most to Acutus Medical Inc in Q4 2021, an estimated $3.52M increase.
  • Sabby Management's biggest Q4 2021 reduction was iPath Series B S&P 500 VIX Short-Term Futures ETN, cutting an estimated $3.33M.
  • Sabby Management fully exited Tricida, Inc. Common Stock in Q4 2021, selling an estimated $3.06M.
  • Sabby Management's ten largest holdings make up 66% of its $688M portfolio in Q4 2021.
  • Sabby Management opened 46 new positions and closed 44 in Q4 2021.
  • Sabby Management's portfolio value fell 7% quarter-over-quarter to $688M.

Based on Sabby Management's 13F filing for Q4 2021, filed 14 Feb 2022.